RK

Rakhi Kumari

Active Director Director DIN 10702812
DIN 10702812 First appointment Jul 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value •••• Premium profile

About Rakhi Kumari

Data last updated:

Rakhi Kumari is a Director at Medizen Global Lifescience Private Limited (since 2024). The company operates in Pharma. Medizen Global Lifescience Private Limited reported revenue of ₹11.5 Lakh (FY 2025).

DIN 10702812
Primary Designation Director
Industry Pharma
First Appointment 11 Jul 2024
Oldest Company Age 2 yrs
Largest company Medizen Global Lifescience Private Limited · ₹11.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Jul 20242024₹11.5 Lakh (FY 2025)Active

Board colleagues of Rakhi Kumari

Directorship timeline

Open interactive timeline →
Medizen Global Lifescience Private Limited
Premium access

Shareholding and investment profile for Rakhi Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakhi Kumari

Rakhi Kumari currently holds 1 directorship: Medizen Global Lifescience Private Limited (Director, since 11 Jul 2024, revenue ₹11.5 Lakh (FY 2025)).

Rakhi Kumari was first appointed on 11 Jul 2024 as Director at Medizen Global Lifescience Private Limited.

The current boards of Rakhi Kumari's companies include Sikha Das (Medizen Global Lifescience Private Limited), Suchandra Kundu (Medizen Global Lifescience Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available